Biotechnology and the Promise of Regenerative Medicine for Aging Populations
American Journal of Biotechnology · 31.12.2024 · 5 (6) · 12-16
DOI: 10.71465/ajbt2440 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biotechnology, online erschienen am 31.12.2024. Verfasst von Dr. Sarah Mitchell und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the global population ages, regenerative medicine has emerged as a promising solution to address age-related diseases and conditions. Biotechnology plays a crucial role in advancing regenerative medicine by providing innovative approaches to tissue repair, cell regeneration, and organ replacement. This article explores the latest advancements in biotechnology for regenerative medicine, focusing on stem cell therapies, tissue engineering, and gene editing. It also discusses the challenges, ethical considerations, and future directions for regenerative medicine in treating aging populations.
Zitieren
APA
Mitchell, D. S., & Harris, D. E. (2024). Biotechnology and the Promise of Regenerative Medicine for Aging Populations. American Journal of Biotechnology, 5(6), 12-16. https://doi.org/10.71465/ajbt2440
Vancouver
Mitchell DS, Harris DE. Biotechnology and the Promise of Regenerative Medicine for Aging Populations. American Journal of Biotechnology. 2024;5(6):12-16. doi:10.71465/ajbt2440
BibTeX
@article{Mitchell2024,
author = {Mitchell, Dr. Sarah and Harris, Dr. Edward},
title = {Biotechnology and the Promise of Regenerative Medicine for Aging Populations},
journal = {American Journal of Biotechnology},
year = {2024},
volume = {5},
number = {6},
pages = {12--16},
doi = {10.71465/ajbt2440}
}
EUVIMED